LOSCHELDER advises Fahl Group on takeover of Orbisana out of insolvency
Insolvency administrator Christian Plail of SGP Schneider Geiwitz has transferred the shares in Orbisana Healthcare GmbH to Andreas Fahl Medizintechnik-Vertrieb GmbH by way of insolvency plan proceedings.
The reason for Orbisana's insolvency was the financial difficulties of the former parent company WB D2C Group GmbH, to which Weltbild also belonged. After filing for insolvency on July 17, 2024, the proceedings were opened before the Augsburg Local Court on October 1, 2024. The insolvency administration team was able to restructure and realign Orbisana.
There were a number of bidders in the investor process conducted by WMCF CORPORATE FINANCE. Andreas Fahl Medizintechnik-Vertrieb GmbH was awarded the contract in view of its future prospects. The acquisition of Orbisana is intended to further expand the range of products and services for patients, hospitals, care facilities and health insurance companies.
On April 10, 2025, the creditors unanimously approved the insolvency plan. The Augsburg Local Court terminated the insolvency proceedings as of May 1, 2025. The restructuring of Orbisana through the implementation of various carve-out measures as well as the capital measures provided for in the insolvency plan have also been completed in the meantime. Over 200 jobs will be saved.
LOSCHELDER accompanied the entire investor and transaction process for the Fahl Group. This included notably the negotiation and conclusion of an investor agreement and the implementation of the insolvency plan.
Insolvency administration
SGP Schneider Geiwitz (Augsburg): Christian Plail (insolvency administrator), Petra Heidenfelder, Dr. Markus Mairgünther, Dirk Weißinger, Stefan Käfferlein (all insolvency administration/restructuring) Dr. Hans-Joachim Machreich, Stephan Schraudner (corporate law/M & A), Dr. Nicole Enke (employment law)
Insolvency administration advisor
Dentons (Berlin): Dr. Holger Ellers (Partner, Lead), Dirk Schone (Partner), Jennifer Brenke (Counsel, all Restructuring), Matthias Hause (Counsel, Corporate/M&A), Jana Winkler (Associate, all Berlin), Tariq Masarwah (Associate, both Restructuring, Frankfurt), Viktor Behrendt (Associate, Restructuring)
Advisors Fahl Group
LOSCHELDER (Cologne): Dr Frank Heerstraßen (Partner, corporate/M&A), Dr Nils Derksen (Partner, distressed M&A, restructuring/insolvency law; joint lead), Dr Martin Brock (Partner, employment law), Dr Cedric Meyer (Partner, public law), Dr Hans Georg Schreier (Partner, commercial), Dr Simon Kohm (Partner, IT/data protection law), Dr Janos Mahlo (Partner, tenancy law); Associates: Dr Fabian Reiter (Senior Associate, restructuring/insolvency law), Dennis Pethke, LL.M (Associate, IT/data protection law)
More about Orbisana and the Fahl Group
Orbisana Healthcare specialices in the care of patients in complex situations - such as patients requiring intensive care and invasive ventilation, as well as patients with laryngeal surgery and complex tracheostomy care.
In addition, Orbisana Healthcare offers comprehensive services in the areas of enteral and parenteral nutrition, modern wound management, oxygen and respiratory therapy as well as incontinence and stoma care.
The Fahl Group, which has specialised in tracheotomy, laryngectomy and ventilation for over 30 years, brings extensive experience and expertise to the new partnership.
If you have any questions about this press release, please contact
Dr Frank Heerstraßen
Phone: +49 221 65065-180
Email: frank.heerstrassen@loschelder.de
Dr Nils Derksen
Phone: +49 221 65065-224
Email: nils.derksen@loschelder.de
